A once-weekly pill that doesn't need refrigeration? Sign me up tbh

Viking Therapeutics just released phase 2 results for VK2735, their dual GLP-1/GIP agonist. The injectable version already showed strong weight loss, but the real news is the oral once-weekly formulation currently in development. That's right, a pill you take once a week, not daily. Early data suggests it maintains steady levels without the strict fasting requirements of daily oral semaglutide.

If this pans out, it could be the perfect middle ground for people who hate needles but also don't want to remember a daily pill. The oral formulation is still in earlier stages, but Viking is moving it forward. This is one to watch for 2027-2028.